Asst. Professor, MD Anderson Cancer Center
Oncology
Dr. Joseph A. Ludwig IV, MD
|
|
Give Review
Dr. Joseph A. Ludwig IV is an expert in the field of Oncology. He researched medicine at University of Iowa Carver College of Medicine. University of Iowa Carver College of Medicine is ranked 29/16 in Research/PrimaryCare. Doctor Joseph A. Ludwig IV, MD is a published MD. He has 18 publications published. The most current publication "Prognostic Factors and Patterns of Relapse in Ewing Sarcoma Patients Treated With Chemotherapy and R0 Resection."
Publications
- Prognostic Factors and Patterns of Relapse in Ewing Sarcoma Patients Treated With Chemotherapy and R0 Resection.
- 3D tissue-engineered model of Ewing's sarcoma.
- Complete Cytoreduction and HIPEC Improves Survival in Desmoplastic Small Round Cell Tumor.
- Modeling Ewing sarcoma Tumors in vitro with 3D scaffolds.
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and Malignant solitary fibrous tumor.
- Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with Cancer: a randomized trial.
- Review: Ewing sarcoma treatment: a role for bisphosphonates?
- Engineering tumors: a tissue engineering perspective in Cancer biology.
- Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.
- Identification of compounds selectively killing multidrug-resistant Cancer cells.
- Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.
- Ewing's sarcoma: standard and experimental treatment options.
- Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
- Personalized therapy of sarcomas: integration of biomarkers for improved diagnosis, prognosis, and therapy selection.
- A stromal gene signature associated with inflammatory breast Cancer.
- Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in Cancer.
- Comparison of drug transporter levels in normal colon, colon Cancer, and Caco-2 cells: impact on drug disposition and discovery.
Schools
University of Ia Roy J amp L Carver Com
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Mayo School of Graduate Medical Education -
University of Iowa Carver College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Similar Doctors
|
|
Dr. Charles Osborne, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott E. Woodman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Nadya Hasham-Jiwa, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald S. Walters, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth W. Rogg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed U. Akhtar, MD |
|
|
Dr. John O. Mendelsohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Stewart, MD |
|
|
Dr. Nicholas Mitsiades, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rashmi K. Murthy, MD |
|
|
Dr. Jennifer Wheler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Wadih Arap, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. George R. Blumenschein Jr., MD |
|
|
Dr. Karin Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan Zhou, MD
This Doctor is OpenDoctor Recommended.
|